JP2008526816A5 - - Google Patents

Download PDF

Info

Publication number
JP2008526816A5
JP2008526816A5 JP2007549909A JP2007549909A JP2008526816A5 JP 2008526816 A5 JP2008526816 A5 JP 2008526816A5 JP 2007549909 A JP2007549909 A JP 2007549909A JP 2007549909 A JP2007549909 A JP 2007549909A JP 2008526816 A5 JP2008526816 A5 JP 2008526816A5
Authority
JP
Japan
Prior art keywords
administered
drug
reperfusion
period
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007549909A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008526816A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2006/050140 external-priority patent/WO2006072639A1/fr
Publication of JP2008526816A publication Critical patent/JP2008526816A/ja
Publication of JP2008526816A5 publication Critical patent/JP2008526816A5/ja
Pending legal-status Critical Current

Links

JP2007549909A 2005-01-10 2006-01-10 心筋虚血状態の間の投与のための薬剤の製造のための環状ウンデカペプチドの使用 Pending JP2008526816A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05000357 2005-01-10
PCT/EP2006/050140 WO2006072639A1 (fr) 2005-01-10 2006-01-10 Utilisation d’un undecapeptide cyclique pour la preparation d’un médicament administrable lors de situations ischemiques myocardiques

Publications (2)

Publication Number Publication Date
JP2008526816A JP2008526816A (ja) 2008-07-24
JP2008526816A5 true JP2008526816A5 (enExample) 2009-02-05

Family

ID=34933239

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007549909A Pending JP2008526816A (ja) 2005-01-10 2006-01-10 心筋虚血状態の間の投与のための薬剤の製造のための環状ウンデカペプチドの使用

Country Status (9)

Country Link
US (1) US8889629B2 (enExample)
EP (1) EP1853296B1 (enExample)
JP (1) JP2008526816A (enExample)
DK (1) DK1853296T5 (enExample)
ES (1) ES2387682T3 (enExample)
PL (1) PL1853296T3 (enExample)
PT (1) PT1853296E (enExample)
SI (1) SI1853296T1 (enExample)
WO (1) WO2006072639A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2023948A1 (en) * 2006-05-04 2009-02-18 Michel Ovize Use of cyclosporin a or melle4-cyclosporin for the treatment of acute myocardial infarction
WO2009098533A1 (en) * 2008-02-08 2009-08-13 Debiopharm Sa Non -immunosuppressive cyclosporin for the treatment of muscular dystrophy
WO2011141891A1 (en) 2010-05-12 2011-11-17 Debio Recherche Pharmaceutique S.A. Use of cycloundecadepsipeptide compounds
GB201217560D0 (en) 2012-10-02 2012-11-14 Mitopharm Ltd Novel cyclic depsipeptide compounds and their uses
EP2967567B1 (en) * 2013-03-15 2022-08-24 Boston Scientific Scimed, Inc. System for controlling a tissue-stapling operation with pressurized fluid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1023441A1 (en) * 1997-10-16 2000-08-02 The Board Of Regents, The University Of Texas System Models and treatments for cardiac hypertrophy in relation with nf-at3 function
CN1289326A (zh) * 1998-02-27 2001-03-28 辉瑞产品公司 用于治疗局部缺血的n-[(取代的五元二氮杂或三氮杂二不饱和环)羰基]胍衍生物
USRE40987E1 (en) 1998-07-01 2009-11-17 Debiopharm S.A. Cyclosporin with improved activity profile
DK1150999T3 (da) * 1999-02-05 2006-10-30 Debiopharm Sa Cyclosporinderivater og fremgangsmåde til fremstilling deraf

Similar Documents

Publication Publication Date Title
JP2010523714A5 (enExample)
Doyon et al. The use of glucagon in a case of calcium channel blocker overdose
JP2015057436A5 (enExample)
ES2704229T3 (es) Agonistas selectivos del receptor AT2 para su uso en el tratamiento de la caquexia
CN103717219B (zh) 左心室舒张功能改善剂
HK1210694A1 (en) Improvement of the bioavailability of active substances having an amidine function in medicaments
JP2020510043A5 (enExample)
KR100399797B1 (ko) 뇌부종억제제
JP2008526816A5 (enExample)
JPWO1996038173A1 (ja) 脳浮腫抑制剤
AU2010277725B2 (en) Otamixaban for treatment of elderly and renal impaired non-ST elevation myocardial infarction patients
JP2023551503A (ja) 抗血栓剤としてのシクロスポリン類似体の使用
CA2482687A1 (en) Treatment of mesothelioma
KR20160080116A (ko) 약학 물질로 사용되는 아미노산 유도체
JPH03505447A (ja) アミオダロンと、ニトロ誘導体、特にイソソルビト二硝酸と、必要に応じてさらにβ―遮断薬とを含む心臓保護効果のある医薬組成物
JP2006503049A5 (enExample)
WO2015178683A1 (ko) p-당단백질의 저해제 및 p-당단백질의 기질 약물을 포함하는 약제학적 조성물
JP2025535826A (ja) 敗血症を処置するためのオルセゲパント
CN1019545B (zh) 制备用于治疗心律不齐的含有喹啉衍生物的组合物的方法
JP2004155661A (ja) 突然死予防剤
EP4463160A1 (en) Treatment for congestive heart failure
JP2022151414A (ja) 虚血性心臓疾患治療薬
RU2004108117A (ru) Нептидиларгинали и способы лечения синдрома диссеминированного внутрисосудистого свертывания
NZ757938B2 (en) Subcutaneous administration of a p2y12 receptor antagonist
Forfia et al. Medical Treatment of PAH: Prostacyclins